Optimind Pharma Corp. (OMND.CN)
| Previous Close | 0.0050 |
| Open | 0.0050 |
| Bid | 0.0000 x N/A |
| Ask | 0.0050 x N/A |
| Day's Range | 0.0050 - 0.0050 |
| 52 Week Range | 0.0050 - 0.0450 |
| Volume | |
| Avg. Volume | 8,636 |
| Market Cap | 490,460 |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0300 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Optimind Pharma Provides Corporate Update
TORONTO, ON / ACCESSWIRE / December 19, 2023 / Optimind Pharma Corp. (CSE:OMND) ("Optimind" or the "Company"), an emerging provider of psychedelic therapies, is pleased to announce that Manitari Pharma Corporation ("Manitari") has received its Controlled ...
- GlobeNewswire
Optimind Pharma Announces Entry Into Acquisition Agreement With Wolf Acquisitions
TORONTO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") is pleased to announce that it has entered into an acquisition agreement dated October 12, 2023 (the "Agreement") with Wolf Acquisitions 1.0 Corp. ("Wolf"), an arm's length private British Columbia corporation, and 1443885 B.C. Ltd. ("Subco"), a wholly-owned subsidiary of the Company, pursuant to which Optimind will acquire all of the issued and outstanding common shares of Wolf (each,
